The Zero Knowledge Proof (ZKP) presale is entering a critical period — Stage 2 ends in just 9 days, with $1.85 million already raised. Meanwhile, Aave and Hedera continue to weaken, with Aave dropping to $106.94 and Hedera falling below $0.09. Market attention is clearly rotating toward early-stage opportunities.
Aave Plunges to $106.94, Below All Key Averages
Aave is trading at approximately $106.94, far below its MA20 ($146.57), MA50 ($156.57), and MA200 ($229.01). The gap shows a clear bearish shift with no immediate recovery signs. Short-term forecasts point to minor moves, but longer outlooks remain negative. Analysts highlight $139.60 as a tough resistance; until cleared, downside risk persists. Aave has dropped off the list of today's top crypto gainers as capital flows into projects with early demand signals.
Hedera Falls Below $0.09, Selling Pressure Mounts
Hedera has slid to $0.0856, below its MA20 ($0.1041), MA50 ($0.1114), and MA200 ($0.1798), confirming seller control. RSI and MACD indicate weak momentum. A short-term bounce to $0.0918 is possible, but the longer trend suggests lower levels. The token must reclaim $0.1065 to change sentiment, otherwise the $0.0820–$0.0940 range may continue. Hedera is also absent from today's top gainers list.
ZKP Presale Stage 2 Window Narrows, Daily Allocation Set to Shrink
ZKP's presale is in its most time-sensitive phase: 9 days remain in Stage 2. The project raised $1.85 million in record time, with a transparent auction structure building community trust. Current daily allocation is 190 million tokens; after Stage 2 ends, it drops to 180 million, tightening supply exactly as interest peaks. The auction is at day 75 of 450, and projections suggest total raise could reach $1.7 billion. Strong early capital inflow, shrinking daily supply, and a long auction runway create a framework analysts see as capable of a potential 100x return.
While Aave and Hedera struggle, ZKP is attracting growing participation. Website, purchase portal, and community links are provided in the original source.

